DaVita Historical Cash Flow
| DVA Stock | USD 166.99 1.48 0.89% |
Analysis of DaVita HealthCare cash flow over time is an excellent tool to project DaVita HealthCare future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Working Capital of 204.3 M or Begin Period Cash Flow of 448.7 M as it is a great indicator of DaVita HealthCare ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining DaVita HealthCare latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether DaVita HealthCare is a good buy for the upcoming year.
DaVita |
About DaVita Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in DaVita balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which DaVita's non-liquid assets can be easily converted into cash.
DaVita HealthCare Cash Flow Chart
Add Fundamental
Free Cash Flow
The amount of cash a company generates after accounting for cash outflows to support operations and maintain its capital assets.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Dividends Paid
The total amount of dividends that a company has paid out to its shareholders over a specific period.Capital Expenditures
Capital Expenditures are funds used by DaVita HealthCare to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of DaVita HealthCare operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Net Income
Net income is one of the most important fundamental items in finance. It plays a large role in DaVita HealthCare financial statement analysis. It represents the amount of money remaining after all of DaVita HealthCare Partners operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.Most accounts from DaVita HealthCare's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into DaVita HealthCare current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. At present, DaVita HealthCare's Change In Cash is projected to increase significantly based on the last few years of reporting. The current year's Free Cash Flow is expected to grow to about 1.6 B, whereas Change To Inventory is projected to grow to (30.5 M).
| 2021 | 2022 | 2023 | 2024 (projected) | Capital Expenditures | 641.5M | 603.4M | 568.0M | 421.6M | Dividends Paid | 244.0M | 267.9M | 308.1M | 160.2M |
DaVita HealthCare cash flow statement Correlations
Click cells to compare fundamentals
DaVita HealthCare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
DaVita HealthCare cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change To Inventory | 10.2M | (12.3M) | 5.7M | (757K) | (32.1M) | (30.5M) | |
| Change In Cash | 793.3M | (706.9M) | 53.2M | (216.0M) | 125.6M | 131.9M | |
| Free Cash Flow | 1.3B | 1.3B | 1.3B | 961.1M | 1.5B | 1.6B | |
| Change In Working Capital | 86.9M | (104.2M) | (140.6M) | 101K | 194.5M | 204.3M | |
| Begin Period Cash Flow | 415.4M | 1.2B | 501.8M | 555.0M | 339.0M | 448.7M | |
| Other Cashflows From Financing Activities | 38.3B | (218.0M) | (238.6M) | (270.3M) | (249.4M) | (237.0M) | |
| Depreciation | 615.2M | 630.4M | 680.6M | 732.6M | 745.4M | 782.7M | |
| Other Non Cash Items | 239.5M | 125.8M | 16.4M | 30.5M | 354.5M | 372.2M | |
| Dividends Paid | 11.4M | 253.1M | 244.0M | 267.9M | 308.1M | 160.2M | |
| Capital Expenditures | 766.5M | 674.5M | 641.5M | 603.4M | 568.0M | 421.6M | |
| Total Cash From Operating Activities | 2.1B | 2.0B | 1.9B | 1.6B | 2.1B | 2.2B | |
| Net Income | 1.0B | 994.7M | 1.2B | 781.6M | 691.5M | 478.4M | |
| Total Cash From Financing Activities | (4.7B) | (1.8B) | (1.1B) | (1.1B) | (1.2B) | (1.1B) | |
| End Period Cash Flow | 1.2B | 501.8M | 555.0M | 339.0M | 464.6M | 474.0M | |
| Stock Based Compensation | 67.9M | 91.5M | 102.2M | 95.4M | 112.4M | 118.0M | |
| Total Cashflows From Investing Activities | 3.0B | (825.4M) | (784.7M) | (630.3M) | (724.9M) | (761.1M) | |
| Change To Account Receivables | (80.0M) | (21.1M) | (138.1M) | (148.4M) | 172.4M | 181.0M | |
| Other Cashflows From Investing Activities | 3.8B | (131.9M) | (128.6M) | 56.7M | 65.2M | 68.4M | |
| Change To Netincome | 292.6M | 346.9M | 179.1M | 50.2M | 57.8M | 54.9M | |
| Sale Purchase Of Stock | (2.4B) | (1.5B) | (1.6B) | (839.6M) | (320.3M) | (336.3M) | |
| Change To Liabilities | 146.9M | 14.7M | (110.5M) | 172.3M | 198.1M | 208.0M | |
| Investments | (14.6M) | (19.0M) | (14.7M) | (83.6M) | (816.8M) | (775.9M) | |
| Change Receivables | (77.2M) | (100.4M) | (9.5M) | (120.9M) | (108.8M) | (114.2M) | |
| Net Borrowings | (2.1B) | (63.5M) | 754.3M | (11.3M) | (10.2M) | (9.6M) | |
| Cash And Cash Equivalents Changes | 371.2M | (693.1M) | 63.2M | (186.9M) | (168.2M) | (159.8M) | |
| Cash Flows Other Operating | 63.4M | 105.1M | (26.4M) | (50.5M) | (58.1M) | (55.2M) | |
| Change To Operating Activities | 145.6M | (20.5M) | (14.8M) | 85.9M | 98.8M | 103.7M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether DaVita HealthCare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of DaVita HealthCare's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Davita Healthcare Partners Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Davita Healthcare Partners Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DaVita HealthCare Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DaVita HealthCare. If investors know DaVita will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DaVita HealthCare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Earnings Share 9.28 | Revenue Per Share 145.293 | Quarterly Revenue Growth 0.046 | Return On Assets 0.0694 |
The market value of DaVita HealthCare is measured differently than its book value, which is the value of DaVita that is recorded on the company's balance sheet. Investors also form their own opinion of DaVita HealthCare's value that differs from its market value or its book value, called intrinsic value, which is DaVita HealthCare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DaVita HealthCare's market value can be influenced by many factors that don't directly affect DaVita HealthCare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DaVita HealthCare's value and its price as these two are different measures arrived at by different means. Investors typically determine if DaVita HealthCare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DaVita HealthCare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.